A brief overview on the use of probiotics to treat overweight and obese patients

Expert Rev Endocrinol Metab. 2020 Jan;15(1):1-4. doi: 10.1080/17446651.2020.1719068. Epub 2020 Jan 28.

Marzieh Daniali^{1

2}, Shekoufeh Nikfar^{3

4

5}, Mohammad Abdollahi^{1

2

3}

¹ Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), the Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
² Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
³ Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
⁴ Evidence-Based Evaluation of Cost-Effectiveness and Clinical Outcomes Group, Pharmaceutical Sciences Research Center (PSRC), and the Pharmaceutical Management and Economics Research Center (PMERC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
⁵ Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

No abstract available

Keywords: Bifidobacterium; Metabolic syndrome; Expert review; Lactobacillus; Obesity; Probiotics.

Publication types